index	text	answer	document_name
0	Columbia shall have the right to terminate this Agreement upon [***] notice to Fleet in the event:<omitted>(ii) a Change of Control Event with respect to Fleet occurs;	Yes	Columbia Laboratories, (Bermuda) Ltd. - AMEND NO. 2 TO MANUFACTURING AND SUPPLY AGREEMENT.PDF
1	In addition, notwithstanding the foregoing, Monsanto, or a subsequent successor, may assign the licenses for the Additional Roundup Products Trademarks upon a Change of Control with respect to Monsanto or a Roundup Sale, provided that Monsanto has provided the Agent with prior written notice of, and has obtained the Agent's prior written consent to, such assignment, which consent shall not be unreasonably withheld.	Yes	Monsanto Company - SECOND A&R EXCLUSIVE AGENCY AND MARKETING AGREEMENT .PDF
2	Subject to requirements of applicable law, FCE will provide notice to ExxonMobil prior to, or promptly after, it becomes aware of any such Change in Control, and if prior notice is prohibited by applicable Law, as soon as practicable or after such notice is no longer prohibited, but in no event later than one (1) business day after any public announcement with respect to any such asset transfer or Change in Control.	Yes	FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement.pdf
3	WEBMD'S AGGREGATE LIABILITY FOR ALL DAMAGES, LOSSES AND CAUSES OF ACTION IN ANY WAY RELATED TO THIS AGREEMENT OR THE CONTENT, WHETHER IN CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, EITHER JOINTLY OR SEVERALLY, SHALL NOT EXCEED FIFTY DOLLARS ($50).	No	WebmdHealthCorp_20050908_S-1A_EX-10.7_1027007_EX-10.7_Content License Agreement.pdf
4	In addition, TPC agrees that Consolidated Artists shall be entitled to the Retainer Fee prorated to the effective date of termination as well any Tournament Bonuses, Money List Bonuses and any Royalty Compensation earned by Consolidated Artists prior to the effective date of termination.	No	TEARDROPGOLFCO_10_23_1996-EX-10.12-ENDORSEMENT AGREEMENT.PDF
5	Effective Date shall be the date of the last signature on the last page of this Agreement.	No	NlsPharmaceuticsLtd_20200228_F-1_EX-10.14_12029046_EX-10.14_Development Agreement.pdf
